GENVEC, INC. 2015 OMNIBUS INCENTIVE PLAN DIRECTOR NON-QUALIFIED STOCK OPTION AGREEMENT COVER SHEETDirector Non-Qualified Stock Option Agreement • March 9th, 2016 • Genvec Inc • Pharmaceutical preparations
Non-Qualified Stock Option This Option is not intended to be an Incentive Stock Option under Code Section 422 and will be interpreted accordingly.
AMENDMENT NO. 1 TO RESEARCH COLLABORATION AND LICENSE AGREEMENTResearch Collaboration and License Agreement • March 9th, 2016 • Genvec Inc • Pharmaceutical preparations • Delaware
This Amendment No. 1 to Research Collaboration and License Agreement (this “Amendment”) is made as of this 10th day of November 2015 (the “Effective Date”), by and between GenVec, Inc., a Delaware corporation (“GenVec”) and Novartis Institutes for Biomedical Research, Inc., a Delaware corporation (“Novartis”), and amends that Research Collaboration and License Agreement dated January 13, 2010 (the “License Agreement”), by and between Novartis and GenVec. Capitalized terms used in this Amendment without definition shall have the meanings given those terms in License Agreement.
GENVEC, INC. 2015 OMNIBUS INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT COVER SHEETIncentive Stock Option Agreement • March 9th, 2016 • Genvec Inc • Pharmaceutical preparations
Incentive Stock Option This Option is intended to be an Incentive Stock Option under Code Section 422 and will be interpreted accordingly. If you cease to be an employee of the Company, its parent, or a subsidiary (“Employee”) but continue to provide Service, this Option will be deemed a Non-qualified Stock Option three (3) months after you cease to be an Employee. In addition, to the extent that all or part of this Option exceeds the $100,000 rule of Code Section 422(d), this Option or the lesser excess part will be deemed to be a Non-qualified Stock Option.
